
5-Amino-1MQ
Not for human consumption
5-Amino-1MQ
A small-molecule NNMT inhibitor studied in metabolic research.
$45 USD per vial
Also known as: 5-Amino-1MQ, 5 Amino, 5-Amino-1-methylquinolinium, NNMT inhibitor
Overview
5-Amino-1MQ (5-amino-1-methylquinolinium) is a small molecule, not a peptide, described in the literature as an inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme involved in nicotinamide, NAD+, and methylation metabolism. It is studied in cell and animal models of metabolic regulation, fat-cell biology, and cellular-energy research, where NNMT activity is examined as a variable. The published evidence is preclinical, and controlled human data are lacking. It is offered here for research use only.
Research highlights
- A small molecule described as an inhibitor of the enzyme NNMT
- Studied for its role in nicotinamide and NAD+ metabolism
- Investigated in models of metabolic regulation
- Explored in fat-cell and cellular-energy research
- Evidence is preclinical, with no controlled human data
Related peptides
- BodyNovaWellness
MOTS-c
20 MGResearch use only
Not for human consumptionSTORE REFRIGERATED 2–8 °C (36–46 °F)$60 USD per vial
A mitochondrial-derived peptide studied in metabolic and exercise research.
- BodyNovaWellness
Tesamorelin
20 MGResearch use only
Not for human consumptionSTORE REFRIGERATED 2–8 °C (36–46 °F)$100 USD per vial
A GHRH analog studied in metabolic and body-composition research.
- BodyNovaWellness
Retatrutide
30 MGResearch use only
Not for human consumptionSTORE REFRIGERATED 2–8 °C (36–46 °F)$100 USD per vial
An investigational triple-receptor agonist studied in metabolic and body-composition research.
- BodyNovaWellness
Tirzepatide
40 MGResearch use only
Not for human consumptionSTORE REFRIGERATED 2–8 °C (36–46 °F)$95 USD per vial
A dual GIP and GLP-1 receptor agonist studied in metabolic research.